FIELD OF THE INVENTION The invention relates to genetic modification of plants, plant cells and seeds, particularly altering carotenoid biosynthesis, and fatty acid composition.

BACKGROUND OF THE INVENTION Carotenoids are pigments with a variety of applications. They are yellow- orange-red lipids which are present in green plants, some molds, yeast and bacteria.

Carotenoid hydrocarbons are referred to as carotenes, whereas oxygenated derivatives are referred to as xanthophylls. The carotenoids are part of the larger isoprenoid biosynthesis pathway which, in addition to carotenoids, produces such compounds as chlorophyll and tocopherols, Vitamin E active agents. The carotenoid pathway in plants produces carotenes, such as oe- and p-carotene, and lycopene, and xanthophylls, such as lutein.

The biosynthesis of carotenoids involves the condensation of two molecules of the C20 precursor geranyl PP to yield the first C40 hydrocarbon phytoene. In a series of sequential desaturations, phytoene yields lycopene. Lycopene is the precursor of the cyclic carotenes, B-carotene and cc-carotene. The xanthophylls, zeaxanthin and lutein are formed by hydroxylation of D-carotene and cc-carotene, respectively.

-carotene, a carotene whose color is in the spectrum ranging from yellow to orange, is present in a large amount in the roots of carrots and in green leaves of plants. -carotene is useful as a coloring material and also as a precursor of vitamin A in mammals. Current methods for commercial production of -carotene include isolation from carrots, chemical synthesis, and microbial production.

A number of crop plants and a single oilseed crop are known to have substantial levels of carotenoids, and consumption of such natural sources of carotenoids have been indicated as providing various beneficial health effects. The below table provides levels of carotenoids that have been reported for various plant species.

CAROTENOID CONTENTS OF VARIOUS CROPS (pg/g) Crop Beta-Carotene Alpha-Carotene Lycopene Lutein Total Carrots 30-110 10-40 0-0.5 0-2 65-120 Pepper (gr) 2 - - 2 8 Pepper (red) 15 1 - - 200 Pumpkin 16 0.3 tr 26 100 Tomato 3-6 - 85 - 98 Watemelon 1 tr 19 - 25 Marigold petals 5 4 - 1350 1500 Red palm oil 256 201 8 - 545 The pathway for biosynthesis of the carotenoids has been studied in a variety of organisms and the biosynthetic pathway has been elucidated in organisms ranging from bacteria to higher plants. See, for example, Britton, G. (1988) Biosynthesis of carotenoids, p. 133-182, In T.W. Goodwin (ed.), Plant pigments, 1988. Academic Press, Inc. (London), Ltd., London. Carotenoid biosynthesis genes have also been cloned from a variety of organisms including Erwinia uredovora (Misawa et al.

(1990) J. Bacteriol. 172:6704-6712; Erwinia herbicola (Application WO 91/13078,

Armstrong et al. (1990) Proc. Natl. Acad. Sci., USA 87:9975-9979); R. capsulatus (Armstrong et al. (1989) Mol. Gen. Genet. 216:254-268, Romer et al. (1993) Biochem. Biophys. Res. Commun. 196:1414-1421); Thermus thermophilus (Hoshino et al. (1993) Appl. Environ. Microbiol. 59:3150-3153); the cyanobacterium Synechococcus sp. (Genbank accession number X63873). See also, application WO 96/13149 and the references cited therein.

While the genes have been elucidated, little is known about the use of the genes in plants. Investigations have shown that over expression or inhibition of expression of the plant phytoene synthase (Psy 1) gene in transgenic plants can alter carotenoid levels in fruits. See, Bird et al. (1991) Biotechnology 9:635-639; Bramley petal. (1992) Plant 2:343-349; and Fray and Grierson (1993) Plant Mol. Biol.

22:589-602. Further, as reported by Fray et al. (1995) The Plant Journal 8:693-701, constitutive expression of a fruit phytoene synthase gene in transgenic tomatoes causes dwarfism by redirecting metabolites from the gibberellin pathway.

Application WO 96/13149 reports on enhancing carotenoid accumulation in storage organs such as tubers and roots of genetically engineered plants. The application is directed towards enhancing colored native carotenoid production in specific, predetermined non-photosynthetic storage organs. The examples of the application are drawn to increasing colored carotenoids in transformed carrot roots and in orange flesh potato tubers. Both of these tissues are vegetative tissues, not seeds, and natively have a high level of carotenoids.

Carotenoids are useful in a variety of applications. Generally, carotenoids are useful as supplements, particularly vitamin supplements, as vegetable oil based food products and food ingredents, as feed additives in aminal feeds and as colorants.

Specifically, phytoene finds use in treating skin disorders. See, for example, U.S.

Patent No. 4,642,318. Lycopene, a- and p-carotene are used as food coloring agents.

Consumption of -carotene and lycopene has also been implicated as having

preventative effects against certain kinds of cancers. In addition, lutein consumption has been associated with prevention of macular degeneration of the eye.

Plant oils are useful in a variety of industrial and edible applications. Novel vegetable oils compositions and/or improved means to obtain oils compositions, from biosynthetic or natural plant sources are needed. Depending upon the intended oil use, various different fatty acid compositions are desired. The demand for modified oils with specific fatty acid compositions is great, particularly for oils high in oleic acid. See, Haumann, B. F. (1996) INFORM 7:320-334. As reported by Haumann, the ideal frying oil would be a low-saturate, high oleic and low linolenic oil.

Furthermore, studies in recent years have established the value of monounsaturated fatty acids as a dietary constituent.

Attempts have been made over the years to improve the fatty acid profiles of particular oils. For example, the oxidative stability of vegetable oil is related to the number of double bonds in its fatty acids. That is, molecules with several double bonds are recognized to be more unstable. Thus, scientists have attempted to reduce the content of cc-linolenic acid in order to improve shelf life and oxidative stability, particularly under heat.

It is apparent that there is needed a method for producing significant levels of carotenoid compounds in crop plants and particularly In plant seeds. It would additionally be beneficial to alter the fatty acid content of the plants and seeds. Such altered seed products would be useful nutritionally as Bell as provide a source for producing more stable oils. There is no report of methods to substantially altering the levels and composition of carotenoids produced in a plant seed, particularly with respect to increasing the level of production of carotenoids. There is therefore needed, a useful method for altering carotenoid levels in plants, particularly seeds, and for producing oils with modified carotenoid composition and/or content.

SUMMARY OF THE INVENTION

Transformed plants, plant cells and seeds having altered carotenoid levels and/or modified fatty acid compositions are provided. The plants, plant cells and seeds are transformed with at least one carotenoid biosynthesis gene, or a combination thereof. Methods for making and using the transformed compositions of the invention are also provided. Methods find use in altering carotenoid levels in plants, particularly seeds, as well as increasing particular compounds for molecular farming, such as for production of particular carotenoids. At the same time, the transformed compositions, particularly seeds, provide a source of modified oils, which oils may be extracted from the seeds in order to provide an oil product comprising a natural source of various carotenoids, carotenoid mixtures. In a particular aspect of the present invention, transformed seed can provide a source for particular carotenoid compounds and/or for modified speciality oils having altered carotenoid compostions and/or altered fatty acid composition, particularly having increased levels of oleic acid and decreased levels of linoleic and linolenic acids.

BRIEF DESCRIPTION OF THE FIGURES Figure 1 shows the nucleotide sequence of the SSU/crtB fusion sequence.

Figure 2 presents constructs for expression of carotenoid biosynthesis genes in plant seeds. Figure 2A shows plasmid pCGN3390 which contains the napin promoter operably linked to the SSUlcrtB sequence. Figure 2B shows plasmid pCGN3392which contains the napin promoter operably linked to the SSUlcrtE sequence. Figure 2C shows plasmid pCGN9010 which contains the napin promoter operably linked to the SSUlcrtl sequence. Figure 2D shows plasmid pCGN9009 which contains the napin promoter operably linked to the SSUlcrtB sequence and the napin promoter operably linked to the SSU/crtl sequence. Figure 2E shows plasmid pCGN9002 which contains the napin promoter operably linked to the SSUlcrtB sequence and the napin promoter operably linked to an antisense epsilon cyclase sequence. Figure 2F shows plasmid pCGN9017 which contains the napin promoter

operably linked to the SSUlcrtB sequence and the napin promoter operably linked to an antisense beta cyclase sequence. Figure 2G shows plasmid pCGN6204 which contains the napin promoter operably linked to the SSUlcrtB sequence and the napin promoter operably linked to the SSU/crtW sequence. Figure 2H shows plasmid pCGN6205 which contains the napin promoter operably linked to the SSU/crtB sequence and the napin promoter operably linked to the crtZ sequence. Figure 21 shows plasmid pCGN6206 which contains the napin promoter operably linked to the SSU/crtB sequence, the napin promoter operably linked to the crtW sequence and the napin promoter operably linked to the crtZ sequence.

Figure 3 shows the results of analyses of saponified samples for control seeds.

Figure 4 shows the results of analyses of saponified samples for pCGN3390 transformed seeds.

Figure 5 shows a graph of the fatty acid analysis in pCGN3390 transformed seeds and demonstrates that the increase in 18:1 fatty acids correlates with a decrease in 18:2 and 18:3.

Figure 6 shows a graph of the fatty acid analysis in pCGN3390 transformed seeds and demonstrates that the increase in 18:1 correlates with an increase in both 18:0 and 20:0, but little effect is seen in 16:0.

Figure 7 shows a graph of the fatty acid analysis in pCGN3390 transformed seeds and demonstrates the increase in 18:0 correlates well with an increase in 20:0.

Figure 8 shows a carotenoid biosynthesis pathway.

Figure 9 provides sequence of B. napus epsilon cyclase cDNA clone 9-4.

FigurelO provides sequence of B. napus epsilon cyclase cDNA clone 7-6.

Figure 11 provides sequence of a B. napus beta cyclase cDNA clone.

Figure 12 provides T2 seed analysis of 3390 transformed Brassica napus plants.

Figure 13 provides T3 seed analysis of 3390 transformed Brassica napus plants.

Figure 14 provides T2 seed analysis of 9002 transformed Brassica napus plants.

Figure 15 shows the nucleotide sequence of the SSU/crtZ fusion sequence.

Figure 16 shows the nucleotide sequence of the SSU/crtW fusion sequence.

Figure 17 shows the HPLC trace for detection of xanthophylls from extractions from seed of 6204 transgenic lines.

DETAILED DESCRIPTION OF THE INVENTION In accordance with the subject invention, methods for increasing production of carotenoid compounds, as well as for altering fatty acid compositions in a plant, particularly in plant seeds, are provided. The method involves transforming a plant cell with at least one carotenoid biosynthesis biosynthesis gene. This has the effect of altering carotenoid biosynthesis, particularly increasing the production of downstream products, as well as providing novel seed oils having desirable fatty acid compositions. A second gene can then be utilized to shunt the metabolic activity to the production of particular carotenoid, or to further alter the fatty acid composition.

Surprisingly, it has been found that transformation of a plant with an early carotenoid biosynthesis gene leads to a significant increase in the flux through the carotenoid pathway resulting in an increase in particular carotenoids. That is, there is an increase in the metabolic activity that can be further manipulated for the production of specific carotenoids. In addition, the transformed seeds may demonstrate altered fatty acid compositions as the result of the carotenoid gene expression, such as seen with the seeds described herein from plants transformed with a phytoene synthase gene.

Thus. using the methods of the invention, seeds are provided which produce high levels of particular carotenoids and/or produce speciality oils having a desired fatty acid composition. In oilseed Brassica, for example, transformation with an early carotenoid biosynthesis gene leads to seeds having significant increases in the levels

of oc-carotene, P-carotene and lutein. In addition, the Brassica seeds demonstrate an altered fatty acid composition and yield a vegetable oil which has increased oleic acid content and decreased linoleic and linolenic acid content. Thus, the transformed seed can provide a source of carotenoid products as well as modified seed oil. In this manner, modified speciality oils can be produced and new sources of carotenoids for extraction and purification are provided.

The oils of the present invention also provide a substantial improvement with respect to stability as compared to two other major plant sources of carotenoids, marigold petals and red palm oil (mesocarp). Although instability is observed in seeds stored in air at room temperature as demonstrated by loss of approximately 20- 30% of total carotenoids after 4 weeks of storage, the loss after 1-2 weeks is only 10%. Palm mesocarp, by contrast, must be processed within a day or two of harvest in order to avoid major losses of carotenoids. Furthermore, the carotenoid decomposition in the seeds of the present invention may be reduced significantly by storage of the seeds under nitrogen.

For the production of a seed having an increase in carotenoid biosynthesis, transformation of the plant with an early carotenoid biosynthesis gene is sufficient.

By early carotenoid biosynthesis gene is intended geranylgeranyl pyrophosphate synthase, phytoene synthase, phytoene desaturase, and isopentenyl diphosphate (IPP) isomerase. A variety of sources are available for the early carotenoid biosynthesis genes and for the most part, a gene from any source can bc utilized. However, it is recognized that because of co-suppression, the use of a plant gene native to the target host plant may not be desirable where increased expression of a particular enzyme is desired.

A number of early carotenoid biosynthesis genes, also referred herein as DNA sequences derived from carotenoid biosynthesis gene coding regions, have been isolated and are available for use in the methods of the present invention. See, for example:

IPP isomerase has been isolated from: R. Capsulatus (Hahn et al. (1996) J.

Bacterial. 178:619-624 and the references cited therein), GenBank Accession Nos.

U48963 and X82627, Clarkia xantiana GenBank Accession No. U48962, Arabidopsis thaliana GenBank Accession No. U48961, Schizosaccharnoyces pombe GenBank Accession No. U21154, human GenBank Accession No. X17025, Kluyveromyces lactis GenBank Accession No. X14230; geranylgeranyl pyrophosphate synthase from E. Uredovora Misawa et al.

(1990) J. Bacteriol. 172:6704-6712 and Application WO 91/13078; and from plant sources, including white lupin (Aitken etal. (1995) PlantPhys.108:837-838), bell pepper (Badillo et al. (1995) Plant Mol. Biol. 27:425-428) and Arabidopsis (Scolnik and Bartely (1994) Plant Physiol. 104:1469-1470; Zhu et al. (1997) Plant Cell Physiol. 38:357-361). phytoene synthase from a number of sources including E. Uredovora, Rhodobacter capsulatus, and plants Misawa et al. (1990) J. Bacteriol. 172:6704-6712, GenBank Accession No. D90087, Application WO 91/13078, Armstrong petal. (1989) Mol. Gen. Genet. 216:254-268, Armstrong, G. A. "Genetic Analysis and regulation of carotenoid biosynthesis. In R. C. Blankenship, M. T. Madigan, and C. E. Bauer (ed.), Anoxygenic photosynthetic bacteria; advances in photosynthesis. Kluwer Academic Publishers, Dordrecht, The Netherlands, Armstrong et al. (1990) Proc. Natl. Acad.

Sci USA 87:9975-9979, Armstrong petal. (1993) Methods Enzymol. 214:297-311, Bartley and Scolnik (1993) J. Biol. Chem. 268:27518-27521. Bartley et al. (1992) J.

Biol. Chem. 267:5036-5039, Bramley et al. (1992) Plant J. 2:291-343, Ray et al.

(1992) Plmzt Mol. Biol. 19:401-404, Ray petal. (1987) Nucleic Acids Res. 15: 10587, Romer et al. (1994) Biochem. Biophys. Res. Commun. 196:1414-1421, Karvouni et al.

(1995) Plant Molecular Biology 27:1153-1162, GenBank Accession Nos. U32636, Z37543, L37405, X95596, D58420, U32636, Z37543, X78814, X82458, S71770, L27652, L23424. X68017, L25812, M87280. M38424, X69172, X63873. and

X60441, Armstrong, G. A. (1994) J. Bacteriol. 176:4795-4802 and the references cited therein; and, phytoene desaturase from bacterial sources including E. uredovora Misawa et al. (1990) J. Bacteriol. 172:6704-6712, and Application WO 91/13078 (GenBank Accession Nos. L37405, X95596, D58420, X82458, S71770, and M87280); and from plant sources, including maize (Li et al. (1996) Plant Mol. Biol. 30:269-279), tomato (Pecker et al. (1992) Proc. Nat. Acad. Sci. 89:4962-4966 and Aracri et al. (1994) Plant Physiol. 106:789), and Capisum annuum (bell beppers) (Hugueney et al. (1992) J. Biochem. 209: 399-407), GenBank Accession Nos. U37285, X59948, X78271, and X68058).

See, generally, Misawa et al. ( 1990) J. of Bacteriology 172:6704-6712, E.P.

0393690 B1, U.S. Patent No. 5,429,939, Bartley et al. (1992) J. Biol. Chem.

267:5036-5039, Bird et al. (1991) Biotechnology 9:635-639, and US Patent No.

5,304,478, which disclosures are herein incorporated by reference.

Transformation with an early carotenoid gene, (herein referred to as the primary gene), increases the biosynthetic activity of the carotenoid pathway, and can lead to increased production of particular carotenoids such as for example, ot- and t3- carotene. As described in more detail in the following examples, by expression of phytoene synthase as the primary gene, large increases in the carotenoid content generally, and particularly in the levels of ot- and -carotene, are obtained in seeds of transformed plants. Oil comprising the carotenoids so produced may be extracted from the seeds to provide a valuable source of cx- and p-carotenes. Such an oil may find use as a food colorant, for example to add color to margarines, or as a food oil.

An edible food oil with high oc- and -carotene levels is of interest for prevention of Vitamin A deficiency which can result in night blindness. Thus, production of transformed plants and extraction of the high (x- and p-carotene oil to provide a useful food oil is particularly desirable in regions where night blindness is a widespread problem, such as in India and Asia.

In addition to high oc- and p-carotene levels, levels of other carotenoids are also increased in the oils exemplified herein. For example, lutein levels are increased in seeds from plants transformed with a phytoene synthase gene, as well as in seeds from plants transformed with a GGPP synthase gene, crtE ( 3392), or with phytoene desaturase, crtl (9010).

Furthermore, additional primary genes may be expressed to provide for even greater flux through the carotenoid pathway. For example, in oilseed Brassica seeds transformed with a phytoene synthase gene as described herein, increased levels of phytoene are observed. Thus, increasing the expression of phytoene desaturase as well as phytoene synthase may result in further increases in the levels of carotenoids, such as ot- and p-carotene and lutein, produced. Such further modification of carotenoid composition is demonstrated here in transgenic plant seeds transformed with pCGN9009 for the expression of crtB and crtI genes. Additionally, plants expressing both phytoene synthase and GGPP synthase genes are desirable. Such plants may demonstrate even greater flux through the carotenoid pathway as indicated by the increased production of chlorophyll observed in plants of the present invention which have been transformed to express a GGPP synthase gene (crtE) in the absence of crtB overexpression.

Interestingly, plants expressing a GGPP synthase gene did not have significant modifications of the tocopherol content. Since GGPP is a branch point of the carotenoid, chlorophyll and tocopherol pathways in plants, these observations suggest that the next enzymatic step in tocopherol biosynthesis, catalyzed by GGPP hydrogenase, is a rate limiting step for tocopherol production. Thus, providing for increased expression of GGPP hydrogenase, alone or in conjunction with increased expression of GGPP synthase would be expected to result in an increase of flux to the tocopherol pathway.

Also of interest are plants which are transformed to express three early carotenoid biosynthesis gens, crtB, crtE, and crtI. Plants expressing two or three

different carotenoid biosynthsis genes may be produced by either transforming a plant with a construct providing for expression of the desired genes, using a multiple gene construct or by cotransformation with multiple constructs, or by crossing plants which contain the different desired genes.

In addition to the production of the carotenoids described herein, once the biosynthetic activity has been increased by expression of the primary carotenoid biosynthesis gene or genes, the pathway can be diverted for the production of specific compounds. The diversion involves the action of at least one second gene of interest, (the secondary gene). The secondary gene can encode an enzyme to force the production of a particular compound or alternatively can encode a gene to stop the pathway for the accumulation of a particular compound. For forcing the production of a particular compound, expression of a carotenoid biosynthesis gene in the pathway for the desired carotenoid compound is used. Genes native or foreign to the target plant host may find use in such methods, including, for example, carotenoid biosynthesis genes from sources other than higher plant. such as bacteria, including Erwinia and Rhodobacter species. For stopping the pathway in order to accumulate a particular carotenoid compound, the secondary gene will provide for inhibition of transcription of a gene native to the target host plant, wherein the enzyme encoded by the inhibited gene is capable of modifying the desired carotenoid compound.

Inhibition may be achieved by transcription of the native gene to be inhibited in either the sense (cosuppression) or antisense orientation of the gene.

For example, for alteration of the carotenoid composition towards the accumulation of higher levels of -carotene derived carotenoids, such as zeaxanthin, zeaxanthin diglucoside, canthaxanthin, and astaxanthin, inhibition of lycopene epsilon cyclase is desired to prevent accumulation of alpha carotene and its derivative carotenoids, such as lutein. In addition, overexpression of lycopene -cyclase may be used to increase the accumulation of p-carotene derived carotenoids. Thus, antisense lycopene epsilon cyclase and lycopene -cyclase are examples of sequences which

find use in secondary gene constructs of interest in the present invention.

Furthermore, in conjunction with the inhibition of lycopene epsilon cyclase, increased expression of additional secondary genes may be desired for increased accumulation of a particular beta-carotene derived carotenoid. For example, increased p-carotene hydroxylase expression is useful for production of zeaxanthin, wherease increased - carotene hydroxylase and keto-introducing enzyme expression is useful for production of astaxanthin. Alternatively, for accumulation of lycopene, inhibition of lycopene beta cyclase or of lycopene epsilon cyclase and lycopene beta cyclase is desired to reduce conversion of lycopene to alpha- and beta-carotene.

Thus, the carotenoid pathway can be manipulated by expression of carotenoid biosynthesis genes to increase production of particular carotenoids, or by decreasing levels of a particular carotenoid by transformation with anti sense DNA sequences which prevent the conversion of a selected precursor compound into the next carotenoid in the pathway.

Secondary genes of interest in the present application include but are not limited to: p-carotene hydroxylase or crtZ (Hundle et al. (1993) FEBS Lett. 315:329-334, GenBank Accession No. M87280) for the production of zeaxanthin; genes encoding keto-introducing enzymes, such as crtW (Misawa et al. (1995) J. Bacteriol. 177:6575-6584, WO 95/18220, WO 96/06172) or -C-4-oxygenase (crtO; Harker and Hirschberg (1997) FEBS Lett. 404: 129-134) for the production of canthaxanthin; crtZ and crtW or crtO for the production of astaxanthin; £-cyclase and £-hydroxylase for the production of lutein; £-hydroxylase and crtZ for the production of lutein and zeaxanthin; lycopene -cyclase (crtY) (Hugueney et al. (1995) Plant J.

8:417-424, Cunningham FX Jr (1996) Plant Cell 8:1613-1626, Scolnik and Bartley (1995) PlantPhysiol. 108:1343, GenBank Accession Nos. X86452,

L40176, X81787, U50739 and X74599) for increased production of p-carotene. antisense lycopene £-cyclase (GenBank Accession No. U50738) for increased production of p-carotene; antisense lycopene £-cyclase and lycopene -cyclase for the production of lycopene; antisense plant phytoene desaturase for the production of phytoene; etc.

In this manner, the pathway can be modified for the high production of any particular carotenoid compound of interest, or for a particular subset of carotenoid compounds, such as xanthophylls. Such compounds include but are not limited to the particular compounds described above, as well as, oc-cryptoxanthin, -cryptoxanthin, 4-carotene, phytofluene, neurosporane, adonixanthin, echineneone, hydroxycanthaxanthin and the like. For a review of xanthophyll production, see Misawa, et al. (1995) supra). Using the methods of the invention, any compound of interest in the carotenoid pathway can be produced at high levels in a seed.

Secondary genes can also be selected to alter the fatty acid content of the plant for the production of speciality oils. For example, acyl-ACP thioesterase genes having specificity for particular fatty acid chain lengths may be used. See, for example, USPN 5,304,481, USPN 5,455,167, WO 95/13390, WO 94/10288, WO 92/20236, WO 91/16421, WO 97/12047 and WO 96/36719. Other fatty acid biosynthesis genes of interest include, but are not limited to, -keto acyl-ACP synthases (USPN 5,510,255), fatty acyl CoA synthases (USPN 5,455,947), fatty acyl reductases (USPN 5,370,996) and stearoyl-ACP desaturases (WO 91/13972).

Of particular interest is the use of a mangosteen acyl-ACP thioesterase as a secondary gene for fatty acid content modification. As described in WO 96/36719 and WO 97/12047, a high stearate content may be obtained in seeds by expression of a mangosteen acyl-ACP thioesterase. To combine the high oleic acid trait of the 3390 plants described herein with the 5266 high stearate plants described in WO 97/12047, crosses were made between 3390-1 and 5266-35 and between 3390-1 and 5266-5.

Seeds resulting from these crosses contained oil having a high stearate, low linoleic, low linolenic and high carotenoid phenotype.

Any means for producing a plant comprising the primary gene or both the primary and secondary genes are encompassed by the present invention. For example, the secondary gene of interest can be used to transform a plant at the same time as the primary gene either by inclusion of both expression constructs in a single transformation vector or by using separate vector, each of which express desired primary or secondary genes. The secondary gene can be introduced into a plant which has already been transformed with the primary gene, or alternatively, transformed plants, one expressing the primary gene and one expressing the secondary gene, can be crossed to bring the genes together in the same plant.

By combining the genes with tissue specific promoters, the carotenoid levels can be altered in particular tissues of the plant. Thus, carotenoid levels in the seed, including embryos and endosperm, can be altered by the use of seed specific transcriptional initiation regions. Such regions are disclosed, for example, in U.S.

Patent No. 5,420,034, which disclosure is herein incorporated by reference.

In this manner, the transformed seed provides a factory for the production of modified oils. The modified oil may be used or alternatively, the compounds in the oils can be isolated. Thus, the present invention allows for the production of particular compounds of interest as well as speciality oils.

The primary or secondary genes encoding the enzymes of interest can be used in expression cassettes for expression in the transformed plant tissues. To alter the carotenoid or fatty acid levels in a plant of interest, the plant is transformed with at least one expression cassette comprising a transcriptional initiation region linked to a gene of interest. Such an expression cassette is provided with a plurality of restriction sites for insertion of the gene of interest to be under the transcriptional regulation of the regulatory regions.

The transcriptional initiation may be native or analogous to the host or foreign or heterologous to the host. By foreign is intended that the transcriptional initiation region is not found the wild-type host into which the transcriptional initiation region is introduced.

Of particular interest are those transcriptional initiation regions associated with storage proteins, such as napin, cruciferin, 8-conglycinin, phaseolin, or the like, and proteins involved in fatty acid biosynthesis, such as acyl carrier protein (ACP). See, U.S. Patent No. 5,420,034, herein incorporated by reference.

The transcriptional cassette will include the in 5'-3' direction of transcription, a transcriptional and translational initiation region, a DNA sequence of interest, and a transcriptional and translational termination region functional in plants. The termination region may be native with the transcriptional initiation region, may be native with the DNA sequence of interest, or may be derived from another source.

Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau et al., (1991), Mol. Gen. Gene, 262:141-144: Proudfoot, (1991), Cell, 64:671-674; Sanfacon et al., (1991), Genes Del 5:141-149; Mogen et al., (1990), Plant Cell, 2:1261-1272; Munroe et al., (1990), Belle. 91: 151-158; Ballas et al., (1989), Nucleic Acids Res., 17:7891-7903; Joshi et al.. (1987), Nucleic Acid Res., 15:9627-9639).

For the most part, the genes of interest of the present invention will be targeted to plastids, such as chloroplasts, for expression. Thus. the carotenoid biosynthesis gene or genes of interest may be inserted into the plastid for expression with appropriate plastid constructs and regulatory elemants. Alternatively, nuclear transformation may be used in which case the expression cassette will contain a gene encoding a transit peptide to direct the carotenoid biosynthesis gene of interest to the plastid. Such transit peptides are known in the art. See, for example, Von Heijne et al. (1991) PlantMol. Biol. Rep. 9:104-126; Clark etal. (1989) J. Biol. Chem.

264:17544-17550; della-Cioppa et al. (1987) Plant Physiol. 84:965-968; Romer et al.

(1993) Biochem. Biophys. Res Common. 196:1414-1421; and, Shah etal. (1986) Science 233:478-481. Plant carotenoid genes useful in the invention may utilize native or heterologous transit peptides.

It is noted that where the gene or DNA sequence of interest is an antisense DNA, targeting to a plastid is not required. In addition, where antisense inhibition of a given carotenoid biosynthesis gene is desired, the entire DNA sequence derived from the carotenoid biosynthesis gene is not required.

The construct may also include any other necessary regulators such as plant translational consensus sequences (Joshi, C.P., (1987), Nucleic Acids Research, 15:6643-6653), introns (Luehrsen and Walbot, (1991), Mol. Gen. Gene, 225:81-93) and the like, operably linked to the nucleotide sequence of interest.

It may be beneficial to include 5' leader sequences in the expression cassette which can act to enhance translation. Translation leaders are known in the art and include: picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5' noncoding region) (Elroy-Stein, O., Fuerst. T.R., and Moss, B. (1989) PNAS USA 86:6126-6130); potyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison et al., (1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology, 154:9-20), and human immunoglobulin heavy-chain binding protein (BiP), (Macejak, D.G., and Sarnow, P., (1991), Nature, 353:90-94; untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4), (Jobling, S.A., and Gehrke, L., (1987), Nature, 325:622-625; tobacco mosaic virus leader (TMV), (Gallie, D.R. et al., (1989), Molecular Biology of RNA, pages 237-256; and maize chlorotic mottle virus leader (MCMV) (Lommel, S.A. et al., (1991), Virology, 81:382-385. See also, Della-Cioppa et al., (1987), Plant Physiology, 84:965-968.

Depending upon where the DNA sequence of interest is to be expressed, it may be desirable to synthesize the sequence with plant preferred codons, or alternatively with chloroplast preferred codons. The plant preferred codons may be

determined from the codons of highest frequency in the proteins expressed in the largest amount in the particular plant species of interest. See, EPA 0359472; EPA 0385962; WO 91/16432; Perlak et al. (1991) Proc. Natl. Acad. Sci. USA 88:3324- 3328; and Murray et al. (1989) Nucleic Acids Research 17: 477-498. In this manner, the nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part of the gene sequence may be optimized or synthetic.

That is, synthetic or partially optimized sequences may also be used. For the construction of chloroplast preferred genes, see USPN 5,545,817.

In preparing the transcription cassette, the various DNA fragments may be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate in the proper reading frame. Towards this end, adapters or linkers may be employed to join the DNA fragments or other manipulations may be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites, or the like. For this purpose, in vitro mutagenesis, primer repair, restriction, annealing, resection, ligation, or the like may be employed, where insertions, deletions or substitutions, e.g. transitions and transversions, may be involved.

The recombinant DNA molecules of the invention can be introduced into the plant cell in a number of art-recognized ways. Those skilled in the art will appreciate that the choice of method might depend on the type of plant, i.e. monocot or dicot, targeted for transformation. Suitable methods of transforming plant cells include microinjection (Crossway et al. (1986) BioTechniques 4:320-334), electroporation (Riggs et al. (1986) Proc. Natal. Acad. Sci. USA 83:5602-5606, Agrobacterium mediated transformation (Hinchee et al. (1988) Biotechnology 6:915-921) and ballistic particle acceleration (see, for example Sanford et al., U.S. Patent 4,945,050; and McCabe et al. (1988) Biotechnology 6:923-926). Also see, Weissinger et al.

(1988) Annual Rev. Genet. 22:421-477; Sanford et al. (1987) Particulate Science and Technology 5:27-37(onion); Christou et al. (1988) Plant Physiol.

87:671 -674(soybean); McCabe et al. (1988) Bio/Technology 6:923-926 (soybean); Datta et al. (1990) Biotechnology 8:736-740(rice); Klein et al. (1988) Proc. Natl.

Acad. Sci. USA, 85:4305-4309(maize); Klein et al. (1988) Biotechnology 6:559-563 (maize); Klein et al. (1988) Plant Physiol. 91:440-444(maize); Fromm et al. (1990) Biotechnology 8:833-839; and Gordon-Kamm et al. (1990) Plant Cell 2:603-618 (maize).

Alternatively, a plant plastid can be transformed directly. Stable transformation of chloroplasts has been reported in higher plants, see, for example, Svab et al. (1990) Proc. Nat'l. Acad. Sci. USA 87:8526-8530; Svab & Maliga (1993) Proc. Nat'l Acad. Sci. USA 90:913-917; Staub & Maliga (1993) Embo J. 12:601-606.

The method relies on particle gun delivery of DNA containing a selectable marker and targeting of the DNA to the plastid genome through homologous recombination. In such methods, plastid gene expression can be accomplished by use of a plastid gene promoter or by trans-activation of a silent plastid-borne transgene positioned for expression from a selective promoter sequence such as that recognized by T7 RNA polymerase. The silent plastid gene is activated by expression of the specific RNA polymerase from a nuclear expression construct and targeting of the polymerase to the plastid by use of a transit peptide. Tissue-specific expression may be obtained in such a method by use of a nuclear-encoded and plastid-directed specific RNA polymerase expressed from a suitable plant tissue specific promoter. Such a system has been reported in McBride et al. (1994) Proc. Natl. Acad. Sci., USA 91:7301-7305.

The cells which have been transformed may be grown into plants in accordance with conventional ways. See, for example, McCormick et al., Plant Cell Reports (1986), 5:81-84. These plants may then be grown, and either self orcrossed with a different plant strain, and the resulting homozygotes or hybrids having the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that the subject phenotypic characteristic is stably maintained and inherited

and then seeds harvested to ensure the desired phenotype or other property has been achieved.

As a host cell, any plant variety may be employed. Of particular interest, are plant species which provide seeds of interest. For the most part, plants will be chosen where the seed is produced in high amounts, a seed-specific product of interest is involved, or the seed or a seed part is edible. Seeds of interest include the oil seeds, such as oilseed Brassica seeds, cotton seeds, soybean, safflower, sunflower, coconut, palm, and the like; grain seeds, e.g. wheat, barley, oats, amaranth, flax, rye, triticale, rice, corn, etc.; other edible seeds or seeds with edible parts including pumpkin, squash, sesame, poppy, grape, mung beans, peanut, peas, beans, radish, alfalfa, cocoa, coffee, tree nuts such as walnuts, almonds, pecans, chick-peas etc.

It is noted that the methods of the present invention have been demonstrated to provide increased carotenoid production in both oilseed Brassica, which has a green embryo, and in cotton, which has a white embryo.

In seed of cotton plants transformed with phytoene synthase, increases of total carotenoid levels ranging from 10 to 300 fold may be obtained. The majority of the increase in carotenoid levels, in this case, about 80%. Is observed as an increase in phytoene levels. Increases in lutein levels are also obtained in this case, ranging from 1.5 to a 5 fold increase. In addition, or-carotene and [3-carotene levels are also increased 10 to 100 fold, with p-carotene levels being '() fold higher than oc-carotene levels. Thus, as seen with Brassica, a second early carotenoid biosynthesis gene, such as phytoene desaturase, may be used with crtB to increase the metabolic flux through the carotenoid/ isoprenoid pathway in cotton to produce a particular carotenoid.

Furthermore, it should also be noted that the methods of the present invention have also been demonstrated herein to provide increased carotenoid production in additional plant species, such as Ambidopsis In seed of Arabidopsis plants transformed with phytoene synthase, increases of total carotenoid levels ranging from 3 to at least approximately 20 fold may be

obtained. A large increase in the level of p-carotene, ranging from 10 to 70 fold, are observed in seeds of transgenic Arabidposis plants. Increases in lutein levels are also obtained in this case, ranging from 1.5 to a 3 fold increase. In addition, phytoene, oc- carotene and lycopene levels are also increased. However, such increases in ot- carotene, phytoene and lycopene are difficult to quantify as these levels are too low to measure in nontransformed control plants. Thus, as seen with Brassica and cotton, a second early carotenoid biosynthesis gene may be used with crtB to increase the metabolic flux through the carotenoid/ isoprenoid pathway in cotton to produce a particular carotenoid and to reduce the increased levels of phytoene.

In one embodiment of the invention, seed transcriptional initiation regions are used in combination with at least one carotenoid biosynthesis gene. This increases the activity of the carotenoid pathway and alters carotenoid levels in the transformed seed. In this manner, particular genes can be selected to promote the formation of compounds of interest. Where the gene selected is an early carotenoid biosynthesis gene the transformed seed has a significant increase in carotenoid biosynthesis as the result of an increase in the flux through the pathway. For Brassica seeds transformed with an early carotenoid biosynthesis gene, significant increases in the production of a-carotene, p-carotene and smaller increases in lutein in the seed oil, as well as altered oil fatty acid compositions are obtained.

Where the early carotenoid biosynthesis gene is phytoene synthase, significant increases of a particular carotenoid include those ranging from a 10 to a 50 fold increase, preferably at least a 50 to a 100 fold increase, more preferably, at least a 50 to a 200 fold increase, such as the increases seen in cc-carotene and -carotene levels.

Lutein levels, in this case, are also increased, but lower increases of 1.5 - 2 fold are obtained. At the same time, total carotenoid levels may be increased at least 10 to 25 fold, preferably 25 to 60 fold, and more preferably 25 to 100 fold. Thus, a seed of the invention transformed with a phytoene synthase gene has a substantial increase in levels of oc- and -carotene and total carotenoids, as well as smaller increases in lutein

and other carotenoids, including phytoene. In some cases, it is not possible to quantitate the fold increase in a given carotenoid compound, as the levels are too low to detect in seeds from comparable non-transformed plants. In Brassica napus, for example, oc-cryptoxanthin, lycopene, phytoene and phytofluene are all detected in various levels in seeds transformed with a crtB gene, but are not detectable in seeds from untransformed Brassica napus plants.

Where the early carotenoid biosynthesis gene is GGPP synthase or phytoene desaturase, 1.5 to 2 fold increases in lutein and -carotene have been obtained in at least one transgenic plant for each gene. Lycopene is also detected in seeds from Brassica napus plants transformed with a crtE (GGPP synthase) gene. Total carotenoids in crtE or crtl transformants are also increased approximately 2 fold.

Chlorophyll levels are also increased in B. napus transgenic plants expressing a crtE gene suggesting an increase in the levels of geranylgeranyl pyrophosphate (GGPP), which is the branch point substrate for carotenoid, chlorophyll and tocopherol biosynthesis. Increases in chlorophyll levels of 1.5 to 2 fold may be obtained in developing and mature seeds. Thus, also of interest as sources of carotenoids are plants which have been engineered to express increased levels of both crtB and crtE.

As demonstrated herein, the effect of one early carotenoid biosynthesis gene on the metabolic energy flux through the carotenoid pathway may be further effected by the addition of a second early carotenoid biosynthesis gene. Thus, the addition of a second early carotenoid biosynthesis gene for increasing the metabolic flow through the carotenoid biosynthesis pathway is also of interest in the present invention, and may find use for production of particular carotenoids either in the presence or absence of a secondary carotenoid biosynthesis gene.

Where the early carotenoid biosynthesis gene phytoene synthase is cotransformed into Brassica napus with a second early carotenoid biosynthesis gene, phytoene desaturase, significant increases of particular carotenoids include increases in cc-carotene, -carotene, and lutein such as observed by expression of crtB alone. In

addition, lycopene and phytoene levels are also increased in such plants, but increases are difficult to quantitate as these levels are too low to be detected in untransformed Brassica napus plants.

Furthermore, when crtI and crtB are both expressed, total carotenoid levels greater than those observed with crtB alone may be obtained. In at least one plant, total carotenoid levels of 1.5 fold those observed in crtB plants were obtained.

Lycopene levels are also increased over levels obtained in seeds of plants transformed with crtB alone. Lycopene levels may be increased from 4 to 15 fold over those obtained in seed of a homozygous crtB plant. In addition, a reduction in the ratio of phytoene to total carotenoids is also obtained, and as a result, levels of cc-carotene and p-carotene are increased 1.2 to 1.8 fold over those obtained with crtB alone. In seeds of plants transformed with phytoene synthase alone, phytoene levels constituted as much as 20% of total carotenoids, while in plants cotransformed with phytoene synthase and phytoene desaturase, phytoene levels represent only 4% to 7% of the total carotenoids.

This metabolic energy effected by transformation with an early carotenoid gene can be funneled into a metabolic compound of choice by transformation with a second gene. As discussed above, the second gene is designed to promote the synthesis of a particular carotenoid by promoting the formation of the carotenoid of interest or alternatively by stopping the pathway to allow for the buildup of compounds. Therefore, significant amounts of carotenoids of interest can be produced in the transformed seeds of the present invention.

Where the primary carotenoid biosynthesis gene phytoene synthase is cotransformed with a secondary carotenoid biosynthesis gene, p-carotene ketolase, increases in levels of cc-carotene, p-carotene and phytoene, such as those seen with transformation with crtB alone, are obtained. Furthermore, echinenone and canthaxanthin levels are also increased. However, such increases are difficult to quantitate as echinenone and canthaxanthin are either not produced in Brassica napus

or the levels are too low to be detected in B. napus plants expressing phytoene synthase alone and nontransformed control plants. Thus, for the production of a specific carotenoid, such as astaxanthin, the addition of a third carotenoid biosynthesis gene, such as p-carotene hydroxylase (crtZ), may find use in the present invention.

Furthermore, the addition of a fourth carotenoid biosynthesis gene, such as phytoene desaturase, may also find use in the present invention.

It should be noted that the carotenoid echinenone is a reaction intermediate in the production of canthoxanthin from p-carotene. The p-carotene ketolase (crtW) could react with the -ring of ot- or p-carotene. One -ring reaction in p-carotene results in echinenone, two -ring reactions in p-carotene form canthaxanthin, and one -ring reaction in cc-carotene makes 4-keto-cc-carotene. This enzyme can not react with the £-ring of a-carotene. Thus, two additional peaks on the HPLC chromatogram are produced in similar amounts, one representing echinenenone, and the other may represent 4-keto-oc-carotene.

Where the primary carotenoid biosynthesis gene phytoene synthase is cotransformed with an antisense secondary carotenoid biosynthsis gene, S-cyclase, large increases in levels of oc-carotene, -carotene and phytoene, such as those seen with transformation with crtB alone, are obtained. Some difference in the ratio of - carotene to cc-carotene is observed as compared to plant. transformed with crtB alone, but large increases in both a-carotene and p-carotene levels are still observed. Lutein levels, on the other hand, are either unchanged, increased. or in some cases decreased by as much as 80% as compared to seeds of untransformed control plants.

Initiation of carotenoid biosynthesis begins at approximately 15 days post anthesis in B. napus seeds, while expression of transformed genes utilizing the napin promoter begins about 18 days post anthesis. Thus, in order to more tightly control the oc-carotene pathway to allow for the build up of p-carotene pathway carotenoids using antisense £-cyclase, an earlier promoter, such as that of the Lesquerella kappa hyrodoxylase (described in pending U.S. patent application 08/898,038, filed 18 July,

1997), may find use. Thus, for increasing levels of a particular carotenoid using antisense, an earlier seed specific tanscriptional initiation region, may be used with a secondary carotenoid biosynthesis gene.

The seeds of the invention which have been transformed with the primary early carotenoid biosynthesis gene also provide a source for novel oil compositions.

The use of phytoene synthase as the primary gene, for example, results in substantial increases in oleic acid content in seed oil. By substantial increase is intended an increase of from about 5% to about 40%, specifically from about 20% to about 40%, more specifically from about 30% to about 40%. Thus, the seeds of the invention which have been transformed with a primary early carotenoid biosynthesis gene provide a source for modified oils having a high oleic acid content. That is, carotenoid biosynthesis genes, particularly early carotenoid biosynthesis genes can be used to produce seeds having at least 70% oleic acid, on a weight percentage basis.

The oleic acid content in any seed can be altered by the present methods, even those seeds having a naturally high oleic acid content. Alteration of seeds having naturally high oleic acid contents by the present methods can result in total oleic acid contents of as high as 80%.

Importantly, there is also a decrease in linoleic and linolenic acid content. By decrease in linoleic fatty acid content is intended a decrease from about 10% to about 25%, preferably about 25% to about 40%, more preferably about 35% to about 60%.

By decrease in linolenic fatty acid content is intended a decrease from about 10% to about 30%, preferably about 30% to about 60%, more preferably about 50% to about 75%. Thus, the methods of the invention result in oils which are more oxidatively stable than the naturally occurring oils. The modified oils of the invention are low- saturate, high oleic and low linolenic. Furthermore, the present invention provides oils high in monounsaturated fatty acids which are important as a dietary constituent.

Based on the methods disclosed herein, seed oil can be modified to engineer an oil with a high oleic acid content as well as a high level of a carotenoid of interest.

High oleic acid and and high cc- and p-carotene oils would have a longer shelf life as both the oleic acid and ot- and p-carotene content would lend stability. It is also noted that such oils are more desirable as sources of carotenoids than the natural red palm oil, which oil contains high levels of saturated fatty acids.

The transformed seed of the invention can thus provide a source of carotenoid products as well as modified fatty acids. Where the intent is to produce particular carotenoid compounds of interest, methods are available in the art for the purification of the carotenoid compounds. In the same manner, methods available in the art can be utilized to produce oils purified of carotenoids. See, generally, WO 96/13149 and Favati et al. (1988) J. Food Sci. 53:1532 and the references cited therein.

The transformed seed and embryos additionally find use as screenable markers. That is, transformed seed and embryos can be visually determined and selected based on color as a result of the increased carotenoid content. The transformed seeds or embryos display a color ranging from yellow to orange to red as a result of the increased carotenoid levels. Therefore, where plant transformation methods involve an embryonic stage, such as in transformation of cotton or soybean, the carotenoid gene can be used in plant transformation experiments as a marker gene to allow for visual selection of transformants. Likewise, segregating seed can easily be identified as described further in the examples.

The following examples are offered by way of illustration and not by way of limitation.

EXPERIMENTAL Example 1 Expression Construct and Plant Transformation A. SSU fusions to E. uredovora carotenoid biosynthesis genes (1) Phytoene Synthase The SSU leader and crtB gene sequences were joined by PCR. The sequence of the SSU/crtB fusion is shown in Figure 1. The crtB gene from nucleotides 5057 to

5363 (numbering according to Misawa et al. (1990) supra) was joined to the SSU leader as follows. A BglII site was included upstream of the SSU leader start site to facilitate cloning. The thymidine nucleotide at 5057 of crtB was changed to an adenosine to make the first amino acid at the SSU leader/crtB junction a methionine, and the splice site a cys-met-asn. The native splice site for SSU is csy-met-gln. Note that Misawa et al. (1990) supra) indicates that the start site for the coding region for crtB is at nucleotide 5096. Thus, there are 13 amino acids upstream of the published start of the coding region for crtB and after the SSU splice site in the crtB/SSU fusion. Twelve of these amino acids are translated from Erwinia crtB upstream sequence and one is the added methionine. The crtB from 5363 (EcoRV) to 6009 (EcoRI) was then attached to the SSU-crtB fusion to obtain a complete SSU-crtB fusion construct designated pCGN3373 (Fig. 1).

(2) Phytoene Desaturase A plasmid comprising a E. uredovora crtI gene fused to the transit peptide sequence of the pea Rubisco small subunit was described by Misawa et al. (The Plant Journal (1993) 4:833-840. An approximately 2.1 kb Xbal/EcoRI fragment of this plasmid containing the SSU-crtl fusion and a nos 3' termination region was cloned in position for expression from a napin 5' promoter.

(3) GGPP Synthase A similar construct containing the SSU transit fused to an E. uredovora crtE gene was obtained. The SSU-crtE fusion is present on an approximately 1.2 kb BglII/BamHI fragment in pCGN3360.

B. SSU fusions to A. auriantiacum carotenoid biosynthesis genes (4) beta-Carotene Hydroxylase (crtZ) The SSU leader and crtZ gene sequences were joined by PCR. The crtZ gene (Misawa, et al. (1995) supra) nucleotide sequence was resynthesized to adjust for plant codon usage. The re synthesized crtZ gene was joined to the SSU leader by PCR as follows. A BglII site was included upstream of the SSU leader translation start site and a XhoI site was included downstream of the crtZ stop codon to facilitate cloning in the napin expression cassette. The nucleotide sequence of the complete ssu:crtZ fusion is shown in Figure 15.

(5) beta-Carotene Ketolase (crtW) The SSU leader and crtW gene sequences were joined by PCR. The crtW gene (Misawa, et al. (1995) supra) nucleotide sequence was resynthesized to adjust for plant codon usage. The re synthesized crtW gene was joined to the SSU leader by PCR as follows. A BglII site was included upstream of the SSU leader translation start site and a XhoI site was included downstream of the stop codon to facilitate cloning in the napin expression cassette. The nucleotide sequence of the complete ssu:crtW fusion is shown in Figure 16.

C. Expression Constructs for Plant Transformation (1) Phytoene Synthase pCGN3373 carrying the complete SSU/crtB fusion was cut with BglII and BamHI to excise the SSUlcrtB fusion. The resulting fragment was ligated into the napin expression cassette in pCGN3223 at the BamHI site (see WO 94/10288 for description of napin expression cassette). The resulting construct, pCGN3389, was digested with HindIII to excise the napin 5'-SSU/crtB-napin 3' fragment, which was then cloned into HindIII cut pCGN1559PASS yielding pCGN3390. pCGN1559PASS is a binary vector for Agrobacteriunl-mediated transformation such as those described

by McBride et al. (Plant Mol. Biol. (1990) 14:269-276) and is prepared from pCGN1559 by substitution of the pCGN1559 linker region with a linker region containing the following restriction digestion sites: Asp7 1 8/AscI/PacI/XbaI/ BamHI/SwaI/Sse8387(PstI)/HindIII. A map of pCGN3390 is provided in Figure 2A.

(2) Phytoene Desaturase A fragment comprising a napin 5'/SSU-crtl fusion/nos 3' construct as described above was cloned into a binary vector for plant transformation resulting in pCGN9010. A map of pCGN9010 is provided in Figure 2C.

(3) GGPP Synthase pCGN3360 carrying the complete SSU/crtE fusion was cut with BglII and BamHI to excise the SSU/crtE fusion. The resulting 1.2 kb fragment was ligated into the napin expression cassette in pCGN3223 at the BamHI site. The resulting construct, pCGN3391, was digested with HindIII to excise the napin promoter- SSU/crtE napin 3' fragment, which was then cloned into HindIII cut pCGN1559PASS yielding pCGN3392. A map of pCGN3392 is provided in Figure 2B.

(4) Phytoene Synthase + Phytoene Desaturase The napin 5'-SSU/crtB-napin 3' fragment from pCGN3389 and the napin 5'/SSU-crtl fusion/nos 3' as present in pCGN9010 were inserted into a binary vector resulting in pCGN9009, shown in Figure 2D.

(5) Antisense Epsilon Cyclase + Phytoene Synthase Brassica napus epsilon cyclase genes are isolated by PCR using primers designed from an Arabidopsis epsilon cyclase gene (Cunningham FX Jr (1996) Plant Cell 8:1613-1626). Sequence of B. napus epsilon cyclase genes is provided in Figures 9 (clone 9-4) and 10 (clone 7-6). An antisense construct is prepared by cloning anXhoI/BamHI fragment of cDNA clone 9-4 into a napin expression cassette (pCGN3223) digested with XhoI and BglII. The napin 5'-antisense epsilon cyclase- napin 3' fragment is cloned along with a napin 5'-SSU/crtB-napin 3' fragment,

fragment into a binary vector for plant transformation, resulting in pCGN9002, shown in Figure 2E.

(6) Antisense Beta Cyclase + Phytoene Synthase Brassica napus beta cyclase genes are isolated by PCR using primers designed from an Arabidopsis beta cyclase gene (Cunningham FX Jr (1996) Plant Cell 8: 1613-1626). Sequence of a B. napus beta cyclase cDNA, 32-3, is provided in Figures 11. An antisense construct is prepared by cloning anXhoI fragment of the beta cyclase cDNA clone into a napin expression cassette (pCGN3223) digested with XhoI. A clone containing the beta cyclase in the antisense orientation is selected. The napin 5'-antisense beta cyclase-napin 3' fragment is cloned along with a napin S SSU/crtB-napin 3' fragment into a binary vector for plant transformation, resulting in pCGN9017, shown in Figure 2F.

(7) beta-Carotene Hydroxylase + Phytoene synthase The vector pCGN9003 was constructed by removing the restriction sites between the crtB coding sequence and the napin 3' sequence by digestion with ClaI and XhoI and filling the ends with klenow creating the vector pCGN9000.

PCGN9000 was digested with Asp7 18, and the fragment containing the napin 5'/SSU:crtB/napin 3' was ligated into the binary vector pCGN5139.

A binary vector for plant transformation, pCGN5 139, was constructed using the neomycin phospho-transferase (nptII) kanamycin resistance gene driven by the CAMV 35S transcriptional initiation region (35S 5') and transcription termination (35S 3') sequences (Fraley et al., Proc. Natl. Acad. Sci (1983) 80:4803-4807, Gardner et al., (1986) Plant Mol Biol 6:221-228). The 35S 5'-nptII-35S 3' fragment was then cloned into a vector containing ori322, Right border (0.5Kb), lacZ, Left Border (0.58Kb), as an Xho I fragment between the Right border-lacZ and Left border sequences. The ColEI and pRi origins of replication as well as the Gentamycin resistance gene were aquired from a derivative of pCGN1532 (McBride and Summerfelt, Plant Molecular Biology, (1990), 14:269-276). Finally, a linker

containing unique restriction sites was synthesized and cloned into the Asp 718/ Hind III (within the lacZ sequence) sites to create the binary vector pCGN5139.

The plastid targeted ssu:crtZ fusion was cloned into the napin pCGN3223 seed expression cassette as a Bgl II -Xho I fragment to generate pCGN6203. The plasmid pCGN6203 carrying the complete napin cassette with ssu:crtZ was digested with NotI to excise the napin cassette containing the ssu:crtZ coding region. The excised fragment was ligated into the Not I site of the binary pCGN9003 carrying the napin SSU:crtB construct. The resulting construct, pCGN6205 (Figure 2H) is a binary vector for Agrobacterium-mediated transformation such as those described by McBride et al. (Plant Mol. Biol. (1990) 14:269-276) and is prepared from pCGN1559 by substitution of the pCGN1559 linker region with a linker region containing the following restriction digestion sites: Asp7 1 8/AscI/Pacl/XbaI/ BamHI/SwaI/Sse8387(PstI)/HindIII. A map of pCGN6205 is provided in Figure 2H.

(8) beta-Carotene Ketolase + Phytoene synthase The ssu crtW plastid targeted fusion was cloned into the napin pCGN3223 seed expression cassette as a Bgl II -Xho I fragment to generate plasmid pCGN6202.

The plasmid pCGN6202 carrying the napin cassette with ssu:crtW was digested with NotI to excise a DNA fragment containing the napin cassette with ssu:crtZ. The resulting fragment was ligated into the Not I site of the binary pCGN9003 (described above) carrying the SSU:crtB napin construct. The resulting pCGN6204 (Figure 2G) is a binary vector for Agrobacterium-mediated transformation such as those described by McBride et al. (Plant Mol. Biol. (1990) 14:269-276) and is prepared from pCGN1559 by substitution of the pCGN1559 linker region with a linker region containing the following restriction digestion sites: Asp7 1 8/AscI/PacI/XbaI/ BamHI/SwaI/Sse8387(PstI)/HindIII. A map of pCGN6204 is provided in Figure 2G.

(9) Phytoene synthase+ beta-Carotene hydroxylase+ beta-Carotene Ketolase

Construct pCGN6203 containing the napin cassette and ssu:crtZ was digested with Hind III to excise the fragment containing napin ssu:crtZ. The resulting HindIII fragment was cloned into the Hind III site of pCGN6204 to generate a triple crt genes binary pCGN6206 that contains napin ssu:crtB+ napin ssu:crtW+ napinssu:crtZ (Figure 21).

D. Plant Transformation Transformed Brassica napus plants containing the above described constructs are obtained as described in Radke et al. (Theor. Appl. Genet. (1988) 75:685-694 and Plant Cell Reports (1992) ll:499-505).

Transformed cotton plants, Gossypium hirsutulzt, containing phytoene synthase may be obtained using methods described in issued U.S. patent No.

5,004,863, and 5,159,135, and in Umbeck et al. (1987) Bio/Technology 5:263-266, or as described in copending application 08/539,176.

Transgenic Arabidopsis thaliana plants containing phytoene synthase may be obtained by Agrobacterium-mediated transformation as described by Valverkens et al., (Proc. Nat. Acad. Sci. (1988) 85:5536-5540), or as described by Bent et al.

((1994), Science 265:1856-1860), or Bechtold et al. ((1993), C. RAcad. Sci, Life Sciences 316:1194-1199).

Example 2 Analysis of Transgenic Plants A. Visual Observations and Segregation Ratios The napin-SSU leader/crtB plants in 212/86 were tagged at 21 days, 28 days and 35 days post anthesis. When the first plant, 3390- l was harvested at 28 days, some of the seeds were obviously orange. AT 35dpa the orange was obvious enough that a segregation ratio could be obtained. This trend of orange seeds has continued and is seen in each of the 17 lines harvested that have been obtained. A table of the segregation ratios is included below in Table 3.

TABLE3 Generation Plant # Orange Green Ratio Chi Square T2 3390-1 291 88 3 to 1 0.64 T2 3390-2 150 22 No fit T2 3390-8 293 87 3 to 1 0.90 T2 3390-4 277 82 3 to 1 0.89 T2 3390-5 243 62 3 to 1 1.90 T2 3390-7 236 89 3 to 1 0.99 T2 3390-6 307 5 63 to 1 0.00 T2 3390-3 121 50 No fit 1.64 T2 3390-11 294 105 3 to 1 0.37 T2 3390-15 287 83 3 to 1 1.30 T2 3390-16 187 65 3 to 1 0.08 T2 3390-17 105 104 No fit T2 3390-12 119 28 3 to 1 2.78 T2 3390-14 283 107 3 to 1 1.23 T2 3390-19 238 94 3 to 1 1.94 T2 3390-20 251 4 63 to 1 0.00 T2 3390-27 229 4 63 to 1 0.04 B. Carotenoid Analysis of Developing Seeds Carotenoids were extracted from seeds harvested at approximately 35 days post-anthesis as follows. Eight seed samples of orange seeds from transgenic plant 3390-1 and eight seed samples of a 212/86 variety rapeseed control plant were ground. in 200cm1 of 70% acetone/30% methanol. The ground seed mixture was then spun in a microcentrifuge for approximately 5 minutes and the supernatant removed. Two additional 70% acetone/30% methanol extractions were conducted with the pelleted seed material and all three supernatants pooled and labeled A/M extract.

At this point in the extraction, the control seed pellets are white, whereas the seed pellets from the transgenic seeds have a yellow color. The pellets are then extracted twice with ether and the resultant supernatants pooled and labeled E extract.

The A/M extract was then transferred to ether as follows. 4501all ether and 600R1 of

water were added to the extracts, followed by removal of the ether layers. The A/M extracts were then washed two more time with 400,ul of ether, and the ether fractions from the three ArM washes pooled. The E extracts described above were washed once with all of water and pooled with the A/M ether fractions. The pooled ether fractions were blown down to a volume of approximately 3001rl with nitrogen gas and filtered using a syringe microfilter. The sample vials were rinsed with approximately 100CLl ether and the rinse was similarly filtered and pooled with the initial filtrate, yielding total volume of approximately 150cell. A 50R1 aliquot was stored at -20YC until further analysis and the remaining 100cell sample was saponified as follows.

100CLl of 10% potassium hydroxide (KOH) in methanol was added to each 100R1 sample and the mixture stored in the dark at room temperature for approximately 2 hours. 400F1 of water was then added to the samples and the ether phase removed.

For better phase separation, saturated NaCI may be substituted for the water. The water solution was then extracted twice more with 1 00us of ether and the ether samples pooled and washed with water.

The saponified samples were then analyzed by HPLC analysis on a Rainin microsorb C18 column (25cm length, 4.6mm outside diameter) at a flow rate of 1.5ml per minute. The gradient used for elution is as follows: A = acetonitrile B = hexane/methylene chloride (1:1) C = methanol.

The initial solution was 70:20:10 (A:B:C). At 2.5 minutes the solution is ramped over 5 minutes to 65:25:10 (A:B:C) and held at this for 12.5 minutes. The solution is then ramped to 70:20:10 (A:B:C) over two minutes followed by a three minute delay prior to injection of the next sample. The absorbance of the eluting samples is continuously monitored at 450 and 280 nm and known chemical and biological standards were used to identify the various absorbance peaks.

In Figures 3 and 4, results of analyses of saponified samples are provided for control and pCGN3390 transformed seeds, respectively. Clear increases in the levels of cc and 8-carotene and phytoene in the transagenic plant seeds are observed, as well as smaller increases in levels of the hydroxylated carotenoid, lutein.

C. Carotenoid and Tocopherol Analysis of Mature Seeds from crtB Transgenic Plants Mature 3390 T2 seed were sent to an analytical laboratory for quantitative analysis using standard HPLC methods known in the art. These results of these analysis are shown in Table 4 below. Compound levels are presented as llg/g.

Seeds designated "Maroon" were selected based on seed color. The seeds which have orange embryos appear maroon colored at maturity as opposed to the black-brown appearance of seeds from wild type plants of this cultivar. Seeds designated as "Random" were not selected for color. As 3390-1 is segregating 3 to 1 for Kan, the "Random" population includes a proportion of nulls. The maroon population contains only transgenics. Due to an effort to exclude nulls from this population, the inclusion of homozygotes may be favored.

TABLE4 COMPOUND CONTROL 3390-1 3390-1 RANDOM MAROON Lutein 7.2 18 26 Zeaxanthin nd* nd nd x-cryptoxanthin nd 8 15 -cryptoxanthin nd nd nd Lycopene nd 2. 3 5. 1 cis-Lycopene nd 2. 9 5. 4 oc-carotene 0.6 124 244 p-carotene 0.9 177 338 cis-I3-carotene 0.2 12 2 6 Other 6 34 51 Total colored carotenoids 14.9 378.2 710.5 Phytoene nd 62 139 Phytofluene nd 24 54 Total all carotenoids 14.9 464.2 903.5 Alpha-tocopherol 74 93 109 Gamma-tocopherol 246 188 95 Delta-tocopherol 3 5 5 *nd = not detected In the non-transgenic sample, "other" includes mostly very polar compounds, such as neoxanthin, violaxanthin, etc. In the transgenic sample "other" includes these and additional compounds, such as zeta-carotene. neurosporene, and mono-cyclic carotenoids.

Results of carotenoid analysis of 3390 T2 seeds from transformed plants of B. napus variety Quantum (SP30021) are presented in Figure 12.

Results of carotenoid analysis of 3390 T3 seeds from transformed plants of B. napus variety 212/86 (SP001) are presented in Figure 13.

The above results demonstrate that a- and p-carotenes levels are significantly increased in the mature seeds as the result of expression of the crtB gene. Generally, the overall increase in carotenoids is quite high, nearly 50 fold for colored carotenoids and up to 60 fold if phytoene and phytofluene are included. It is clear that the flux through the isoprenoid pathway has been dramatically increased. Additionally it is noted that the cc-tocopherol (Vitamin E) levels are also increased by nearly 50%.

D. Germination Studies Ten mature seeds of 3390-1 and 10 seeds of 212/86 control were planted in soil and grown in a walk-in growth chamber. The transgenics emerged 1 to 2 days later than the controls, however, all 10 seeds did germinate. The transgenics were yellowish-pink when they first emerged but greened up in one to two days. At the emergence of the first true leaf, no difference in color was observed. Plants germinated from both the transgenic and control seeds developed normally.

E. Fattv Acid Analysis Fatty acid composition of mature seeds was determined by GC analysis of single T2 seeds harvested from trangenic plants 3390-1 and 3390-8. Single seeds from both Random (R) and Maroon (M) populations (as defined above) were analyzed and compared to seeds from a 212/86 control (SP001-l). The results of these analyses are provided in Table 5 below as weight % total fatty acids.

TABLE 5 FATTY ACID COMPOSITION OF 3390-1 AND 3390-8 LINES SAMPLE 10:0 12:0 14:0 16:0 16:1 18:0 18:1 18:2 18:3 20:0 20:1 20:2 22:0 CONTROL 1.5 0 0.1 5.1 0.4 1.7 59.9 17.1 12.0 0.6 1.2 0.1 0.3 CONTROL 1.8 0 0.1 5.1 0.4 1.7 60.1 16.6 12.1 0.6 1.2 0.1 0.3 CONTROL 2.0 0 0.1 5.0 0.4 1.6 60.5 16.2 12.0 0.6 1.2 0.1 0.3 CONTROL 2.2 0 0.1 5.2 0.4 1.6 57.2 18.2 12.7 0.6 1.3 0.1 0.4 CONTROL 1.6 0 0.1 4.7 0.4 1.8 62.7 15.3 11.3 0.6 1.2 0.1 0.3 3390-1-R 2.8 0 0.1 4.8 0.5 3.6 69.9 10.6 4.8 1.2 1.1 0.0 0.6 3390-1-R* 1.5 0 0.1 4.7 0.3 1.5 58.1 19.3 12.3 0.5 1.2. 0.1 0.3 3390-1-R 3.5 0 0.1 4.2 0.3 2.6 71.1 9.6 5.8 1.0 1.2 0.0 0.6 3390-1-R* 1.5 0 0.1 4.7 0.3 1.9 61.0 17.8 10.4 0.7 1.3 0.1 0.3 3390-1-R 2.2 0 0.1 4.4 0.3 3.1 73.6 8.9 4.4 1.2 1.1 0.0 0.7 3390-1-R 1.9 0 0.1 4.5 0.3 2.4 72.7 10.6 4.7 0.9 1.3 0.1 0.6 3390-1-R 2.5 0 0.1 4.2 0.3 3.4 71.7 10.0 5.1 1.1 1.0 0.0 0.6 3390-1-R 1.7 0 0.1 4.4 0.3 2.6 73.5 10.0 4.5 1.0 1.2 0.1 0.6 3390-1-R 1.9 0 0.1 4.2 0.3 2.3 72.4 9.9 6.3 0.9 1.2 0.1 0.5 3390-1-R 2.5 0 0.1 4.2 0.3 2.7 72.0 10.1 5.1 1.0 1.2 0.1 0.6 3390-1-R* 1.5 0 0.1 4.7 0.3 1.7 58.5 18.5 12.6 0.6 1.2 0.1 0.3 3390-1-R 2.8 0 0.1 4.6 0.4 3.7 71.8 9.1 4.2 1.3 1.2 0.0 0.7 3390-1-R 1.8 0 0.1 4.0 0.3 2.3 72.4 11.1 5.2 0.9 1.3 0.1 0.5 3390-1-fl 1.7 0 0.1 4.4 0.3 2.7 73.9 9.9 4.2 1.0 1.2 0.1 0.6 3390-1-R 1.7 0 0.1 4.6 0.4 2.6 71.4 10.9 5.5 1.0 1.3 0.1 0.6 3390-1-R 2.7 0 0.1 4.2 0.3 2.8 72.1 9.9 5.0 1.1 1.3 0.0 0.6 3390-1-R 2.0 0 0.1 4.5 0.3 3.0 72.5 9.7 4.6 1.2 1.3 0.1 0.7 3390-1-R 1.8 0 0.1 4.9 0.4 3.4 71.8 10.4 4.2 1.2 1.2 0.0 0.7 3390-1-R* 0.9 0 0.1 4.5 0.3 1.7 55.9 18.8 15.6 0.5 1.3 0.1 0.3 3390-1-R* 1.4 0 0.1 4.8 0.4 1.7 57.1 18.0 14.4 0.6 1.2 0.1 0.3 3390-1-R* 1.4 0 0.1 4.5 0.3 1.7 57.8 18.5 13.5 0.6 1.3 0.1 0.3 3390-1-R 2.2 0 0.1 4.5 0.3 2.5 73.4 9.7 4.6 0.9 1.2 0.0 0.5 3390-1-R 1.5 0 0.1 3.8 0.3 2.7 75.9 8.1 4.6 1.0 1.4 0.0 0.6 3390-1-R 1.6 0 0.1 4.5 0.3 2.6 71.9 10.6 5.5 1.0 1.3 0.1 0.6 3390-1-R* 1.3 0 0.1 6.2 0.5 1.4 53.6 21.7 13.2 0.5 1.1 0.1 0.3 3390-1-R 2.1 0 0.1 4.3 0.3 2.4 72.3 10.7 5.1 0.9 1.2 0.0 0.6 3390-1-R* 1.3 0 0.1 5.0 0.3 1.6 57.8 18.8 13.0 0.5 1.3 0.1 0.3 3390-1-R 2.1 0 0.1 4.4 0.3 3.3 72.7 9.2 4.8 1.2 1.2 0.0 0.7 3390-1-R 1.5 0 0.1 4.5 0.3 3.3 72.6 10.1 4.6 1.2 1.1 0.1 0.7 3390-1-R* 1.2 0 0.1 4.7 0.3 1.9 59.9 17.1 12.6 0.6 1.3 0.1 0.4 3390-1-M 2.8 0 0.1 4.0 0.3 2.8 69.8 10.6 7.1 0.9 1.2 0.0 0.4 3390-1-M 2.0 0 0.1 4.9 0.4 3.3 70.3 11.1 4.9 1.2 1.2 0.1 0.7 3390-1-M 1.5 0 0.1 4.4 0.3 3.2 73.4 9.5 4.3 1.3 1.3 0.0 0.8 3390-1-M 1.5 0 0.1 4.5 0.3 2.8 72.7 10.0 5.1 1.1 1.3 0.0 0.7 3390-1-M 1.8 0 0.1 4.2 0.3 3.1 73.5 9.6 4.7 1.1 1.2 0.0 0.6 3390-1-M 1.5 0 0.1 4.7 0.3 2.9 71.6 10.7 5.1 1.1 1.2 0.1 0.7 3390-1-M 1.5 0 0.1 4.5 0.3 3.2 72.6 10.2 4.3 1.2 1.3 0.0 0.8 3390-1-M 1.8 0 0.1 4.4 0.3 2.9 72.0 10.4 5.2 1.1 1.2 0.1 0.6 3390-1-M 1.5 0 0.1 4.4 0.3 2.6 73.6 10.0 4.5 1.1 1.2 0.1 0.7 3390-1-M 2.3 0 0.1 4.3 0.3 3.0 73.0 9.7 4.5 1.1 1.2 0.0 0.6 SAMPLE 10:0 12:0 14:0 16:0 16:1 18:0 18:1 18:2 18:3 20:0 20:1 20:2 22:0 3390-8-R* 1.0 I 0 0.1 4.9 0.3 1.6 59.2 18.9 11.9 0.5 1.2 0.1 0.3 3390-8-R 2.1 0 0.1 4.2 0.3 2.7 71.9 10.2 5.6 1.0 1.2 0.1 0.6 3390-8-R 1.5 0 0.1 4.4 0.3 2.3 72.5 10.4 5.7 0.9 1.4 0.1 0.6 3390-8-R* 1.2 0 0.1 4.9 0.3 1.7 59.7 18.2 11.6 0.6 1.3 0.1 0.4 3390-8-R* 1.5 0 0.1 4.7 0.3 1.6 58.7 18.5 12.2 0.6 1.3 0.1 0.4 3390-8-R 1.8 0 0.1 4.2 0.3 2.9 73.4 9.2 5.2 1.1 1.3 0.0 0.6 3390-8-R* 1.1 0 0.1 4.7 0.3 1.5 56.9 19.3 14.1 0.5 1.1 0.1 0.2 3390-8-R 2.2 0 0.1 4.6 0.3 3.0 71.4 10.0 5.2 1.1 1.2 0.1 0.7 3390-8-R 1.7 0 0.1 4.6 0.4 2.4 72.5 11.0 4.8 0.9 1.3 0.1 0.5 3390-8-R 2.4 0 0.1 4.7 0.3 2.9 74.0 8.4 4.0 1.1 1.2 0.0 0.7 3390-8-R 1.9 0 0.1 4.6 0.4 3.0 72.7 9.7 4.8 1.0 1.2 0.0 0.6 3390-8-R 2.0 0 0.1 4.4 0.3 2.8 73.2 9.7 4.5 1.0 1.3 0.0 0.6 3390-8-R 1.5 0 0.1 4.3 0.3 2.6 71.8 10.7 5.8 1.0 1.3 0.1 0.6 3390-8-R 1.5 0 0.1 4.4 0.3 2.7 72.6 10.5 4.9 1.0 1.3 0.1 0.6 3390-8-R 2.0 0 0.1 4.9 0.4 3.3 71.1 10.4 4.9 1.1 1.1 0.1 0.6 3390-8-R 2.1 0 0.0 4.5 0.4 3.6 73.0 8.8 4.3 1.3 1.2 0.0 0.7 3390-8-R 2.2 0 0.1 5.1 0.4 2.9 67.6 12.3 6.5 1.1 1.2 0.1 0.7 3390-8-R 1.8 0 0.1 4.2 0.3 2.6 73.5 9.9 4.8 1.0 1.3 0.1 0.6 3390-8-R 1.7 0 0.1 4.7 0.3 3.0 72.5 9.9 4.6 1.2 1.3 0.1 0.7 3390-8-R 1.7 0 0.1 4.6 0.4 2.8 73.7 9.5 4.1 1.1 1.3 0.1 0.7 3390-8-R 1.5 0 0.1 4.5 0.3 3.0 74.7 8.5 4.2 1.2 1.2 0.0 0.7 3390-8-R 1.5 0 0.1 4.4 0.4 1.9 70.0 11.8 7.2 0.8 1.4 0.1 0.5 3390-8-R 1.7 0 0.1 4.4 0.3 2.5 71.8 11.1 5.2 1.0 1.3 0.1 0.6 3390-8-R 1.4 0 0.1 4.5 0.4 2.8 73.3 9.7 4.9 1.1 1.2 0.1 0.6 3390-8-R 1.5 0 0.1 4.8 0.4 3.0 72.6 10.6 4.1 1.1 1.2 0.1 0.7 3390-8-R* 1.4 0 0.1 5.8 0.4 2.9 54.0 20.0 13.0 0.8 1.1 0.1 0.4 3390-8-R 1.4 0 0.1 4.4 0.3 2.7 71.2 10.8 6.0 1.0 1.3 0.1 0.6 3390-8-R 1.7 0 0.1 4.6 0.4 2.8 72.6 10.0 5.1 1.0 1.2 0.1 0.6 3390-8-R* 1.0 0 0.1 4.6 0.3 1.6 59.6 18.5 12.3 0.5 1.2 0.1 0.3 3390-8-R* 1.1 0 0.1 4.6 0.3 1.4 56.5 20.4 13.4 0.5 1.3 0.1 0.3 3390-8-M 1.8 0 0.1 4.7 0.4 3.3 70.1 11.1 5.5 1.2 1.1 0.1 0.7 3390-8-M 1.5 0 0.1 4.3 0.3 3.0 73.0 10.3 4.3 1.1 1.2 0.1 0.7 3390-8-M 1.9 0 0.1 4.5 0.4 3.7 73.1 8.9 4.2 1.3 1.2 0.0 0.7 3390-8-M 1.6 0 0.1 4.4 0.3 2.5 73.4 9.7 5.1 1.0 1.3 0.1 0.7 3390-8-M 1.3 0 0.1 4.4 0.3 3.0 73.7 9.6 4.4 1.1 1.3 0.0 0.7 3390-8-M 2.1 0 0.1 4.3 0.3 3.2 74.0 8.9 4.1 1.2 1.2 0.1 0.6 3390-8-M 2.1 0 0.1 3.9 0.3 1.6 71.6 11.9 5.7 0.7 1.5 0.1 0.5 3390-8-M 1.6 0 0.1 4.6 0.3 2.8 71.0 11.8 4.8 1.0 1.3 0.1 0.6 3390-8-M 2.1 0 0.1 4.8 0.4 3.2 70.3 10.7 5.2 1.2 1.2 0.1 0.7 3390-8-M 1.6 0 0.1 4.5 0.3 2.9 72.7 9.9 4.8 1.1 1.3 0.0 0.7

The above data demonstrate a substantial increase in oleic acid (18:1) in seeds from each of the transgenic lines. The increase in oleic acid is at the expense of linoleic and linolenic acids, both of which were decreased in the transgenic lines.

Increases in 18:0 and 20:0 fatty acids were also observed. Based on these data, the null seeds present in the Random population can be identified, and are marked on Table 5 with an asterisk (*). All of the seeds in the Maroon populations from each transgenic line have the observed altered fatty acid compostion, confirming that the altered fatty acid composition is the result of expression of the crtB gene.

The trends in fatty acid composition data in the transgenic seeds which indicate positive and negative correlations of fatty acid composition changes with the observed increase in 18:1 levels are provided in Figures 5-7. The increase in 18:1 correlateswith the decreases in 18:2 and 18:3. (Figure 5). The increase in 18:1 also correlates with an increase in both 18:0 and 20:0, but little effect on 16:0 was seen (Figure 6). The increase in 18:0 also correlated with an increase in 20:0 (Figure 7).

F. Carotenoid Analysis of Mature Seeds from crtE Transgenic Plants Carotenoids were analyzed in mature T2 seeds of 3392 B. napus plants tranformed to express the E. uredovora crtE gene. Approximately two fold increases in levels of lutein and B-carotene was observed in seeds of plant 3392-SP30021-16.

Lycopene was also detected in these seeds and Is undetcctable in seeds of untransformed control plants. Analysis of seeds from 7 additional 3392 transformants did not reveal significant increases in thc carotenoid levels.

G. Analysis of Chlorophyll and Tocopherol Levels In c rtE Transgenic Plants Chlorophyll levels were analyzed using a spectrophotometric assay (Bruinsma, J. 1961, A comment on the spectrophotometric determination of chlororphyll, Biochem Biophy Acta, 52:576-578) in mature T2 seeds of transgenic 3392 B. napus plants. Levels in 3392 transgenic plants were compared to seeds of transgenic B. napus plants expressing phytoene synthase ( crtB) and to nontransformed control plants. Results are shown in Table 6 below.

TABLE 6 Pigment concentration (llg/gFW) Gene and sample Total carotenoids Total chlorophyll Phytoene synthase 27 DPA SP001 control 53 676 27DPAT43390-l-6 354 282 40 DPA SP001 control 47 471 40DPAT43390-l-6 534 179 50 DPA SP001 control 16 125 50 DPA T4 3390-1-6 648 125 GGPP synthase 35 DPA SP30021 control 68 407 35 DPA T2 3392-4 65 660 35 DPA T2 3392-16 73 648 Mature SP30021 control 21 35 Mature T2 3392-4 25 31 Mature T2 3392-16 50 60 Chlorophyll concentrations of the 35 DPA seeds of two lines were increased by approximately 60% compared to the levels of the control plant. The initial results demonstrate that the GGPP synthase gene increased the GGPP substrate availability for chlorophyll biosynthesis during seed development. Mature seeds of the 3392-16 line had higher chlorophyll and carotenoid concentrations than those of the control.

H. Carotenoid Analysis of Mature Seeds from crtI Transgenic Plants.

Carotenoids were analyzed in mature T2 seeds of 9010 B. napus plants tranformed to express the antisense lycopene £-cyclase gene. Seeds of nine transgenic plants were analyzed for carotenoid content. An approximately two fold increase in levels of lutein, -carotene and total carotenoids was observed in seeds of one line, 9010-SP30021-10, when compared to control plants.

I. Carotenoid Analysis of Mature Seeds from crtB + crtl Transgenic Plants Carotenoid levels of Mature 9009 T2 seeds were extracted and quantified on an HPLC as follows. Approximately 100mg of seeds were ground in a mortar and pestle in 3ml extraction solvent ( hexane/acetone/ethanol ( 50/25/25 v/v) with 0.2ml of an internal standard ( 5mg/ml -apo-8' carotenal ( dissolved in 1001rl hexane), in acetonitrile/methylene chloride/methanol ( 50/40/10, v/v/)). The extraction solution was transfered to a new glass tube, and the remaining seed was again extracted with the extraction solvent and pooled with first extraction solution. The extraction was repeated until no color was visible in the extraction solution. Pooled extracts were mixed by vortexing briefly, then centrifuged for approximately 5 minutes. The resulting supernatant was transfered to a new tube and dried under nitrogen gas. The residue was resuspended in 2ml of hexane. Potassium hydroxide, in methanol, was added to a final concentration of 5%, and the solution was incubated overnight in the dark at 40C. Another 2ml of hexane was then added to the solution with lml of saturated sodium chloride. The solution was mixed briefly by vortexing and centrifuged for approximately 5 minutes. The upper hexane layer was removed and transfered to a new glass tube. The remaining bottom phase was again extracted with hexane and centrifuged. The upper phase was combined with the previous hexane phase. This was repeated until the hexane phase was colorless. The pooled hexane phases were dried under nitrogen gas, and the residue was dissolved in 2.0ml of acetonitrile/methylene chloride/methanol ( 50/40/10 v/v). The solution was filtered through a 0.45m filter and colected in a brown autopsampler vial. Carotenoid concentrations were determined on a Hewlett Packard 1050 High-Performance Liquid Chromatograph (HPLC), and isocratic separation of carotenoids was performed on a Hewlett Packard reverse phase C-18 ( 5R) column (4.6 mm x 20cm) at 300C. The mobile phase was acetonitrile/ methylene chloride/ methanol (80/10/10, v/v) with a flow rate of 1 .Oml/min and a sample injection volume of 20,u1 (running time of 22min). Routine detection of colored carotenoids is at 450 nm, phytoene at 280 nm,

and phytofluene at 365 nm. Spectral scans for peak purity were made at 250 nm and 600 nm. Spectra of peaks at the upslope, apex, and downslope are normalized and overlaid. Superimposing spectra were taken as evidence of peak purity. The results are shown in Table 7 below. Carotenoid levels are presented as ,ug/gFW.

TABLE 7 Sample ID # Lutein Lycopene a-Carotene -Carotene Phytoene Total SP30021 control 36 ND ND 4 ND 40 3390-SP001-1-6-15 (T5 Homo) 54 4 552 638 277 1525 9009-SP30021-1 44 44 336 691 42 1157 9009-SP30021-6 53 87 689 1118 152 2099 9009-SP30021-9 48 34 487 798 194 1561 9009-SP30021-10 33 25 248 489 34 829 9009-SP30021-12 31 ND ND 2 ND 33 9009-SP30021-14 42 37 404 791 81 1355 9009-SP30021-15 37 15 137 278 ND 467 9009-SP30021-16 50 38 428 828 65 1409 The results demonstrate that as with plants transformed to express crtB alone, plants expressing crtB and crtI contain significant increases in total carotenoid levels.

Furthermore, it is apparent that expression of crtI with crtB, leads to further modification of the phytoene pools which accumulate in crtB transformants. Phytoene levels were reduced from about 20% of total carotenoids in lines transformed with crtB alone, to 4% to 7% of total carotenoids in the crtB + crtI lines. This indicates that phytoene desaturase can have a synergistic effect with phytoene synthase in increasing the metabolic flux through the carotenoid/ isoprenoid pathway, and provides for even greater increases in a desired carotenoid compound, such as oc- carotene and '3-carotene, than is obtained by expression of crtB alone. The increased flux also appears to result in increased total carotenoid production, in addition to the composition shift from phytoene. For example, the carotenoid levels in the

segregating T2 seed populations of 9009-10 are significantly higher than those detected in the 3390 homozygous seed population in 3390-1-6-15.

J. Carotenoid Analysis of mature Seeds from crtB + Antisense £-Cyclase Transgenic Plants Carotenoids from mature seeds from 9002 transformants were extracted and analyzed using the method described in example 21 above. These results are shown in Figure 14.

The initial results show a modification to the ratio of -carotene to a-carotene.

In addition, several lines show a significant reduction in lutein levels when compared to nontransgenic controls. In 9002 T2 lines, p-carotene to cc-carotene ratios averaged 1.5, ranging from 1.1 to 2.5. For comparison, T2 3390 lines containing crtB, the ratio of p-carotene to cc-carotene averaged 1.9, ranging from 1.5 to 2.4.

K. Carotenoid Analysis of Mature Seeds from crtB Transgenic Cotton Plants Mature 3390 T2 seeds from cotton were collected and carotenoid extracts were prepared and analyzed according to the method described in 21 above. These results are shown in Table 8 below. Carotenoid levels are presented as ,ug/gFW.

TABLE 8 Sample ID # Lutein Lycopene o-Carotene '3-Crotene Phytoene Total C130 control 2 ND ND ND ND 2 3390-C130-5-1 7 ND 486 42(.) 517 An approximately 3 fold increase in lutein was observed in seeds of plant 3390-C130-5-1. Alpha-carotene, -carotene and phytoene were also observed in this line and are undetectable in nontransformed control plants. With -carotenoid levels being 20 fold higher than those of cc-carotene. Total carotenoid levels were increased by more than 250 fold, with phytoene accounting for approximately 80% of that total.

L. Carotenoid Analysis of Mature Seed from crtB + crtW Transgenic Plants Carotenoid levels of Mature 6204 T2 seeds were extracted and quantified on an HPLC as follows. Approximately 100mg of seeds were ground in a mortar and pestle in 3ml extraction solvent ( hexane/acetone/ethanol ( 50/25/25 v/v) with 0.3ml of an internal standard ( Smg/ml -apo-8' carotenal ( dissolved in 100R1 hexane), in acetonitrile/methylene chloride/methanol ( 50/40/10, v/v/)). The extraction solution was transfered to a new glass tube, and the remaining seed was again extracted with the 2 ml extraction solvent and pooled with first extraction solution. The extraction was repeated until no color was visible in the extraction solution. Pooled extracts were mixed by vortexing briefly, then centrifuged for approximately 5 minutes. The resulting supernatant was transfered to a new tube and dried under nitrogen gas. The dried sample was stored in the dark overnight at 40C. The residue was resuspended in 3ml of hexane and 1 ml methanol, and 1 ml of saturated sodium chloride was added and mixed. The samples were centrifuged briefly, and the upper phase was transferred to a new tube. The remaining bottom phase was again extracted with 2 ml hexane and centrifuged. The upper phase was combined with the previous hexane phase. This was repeated until the hexane phase was colorless. The pooled hexane phases were dried under nitrogen gas, and the residue was dissolved in 2.0ml of acetonitrile/methylene chloride/methanol ( 50/40/10 v/v). The solution was filtered through a 0.45m filter and colected in a brown autopsampler vial. Carotenoid concentrations were determined on a Hewlett Packard 1100 High-Performance Liquid Chromatograph (HPLC), and isocratic separation of carotenoids was performed on a Spherisorb ODS2 reverse phase C-18 (spy) column (4.6 mm x 25cm) at 30"C. The mobile phase was 82 acetonitrile/ 10 dioxane /8 methanol (v/v) containing 150 mM ammonium acetate/ 0.1 triethylamine, with a flow rate of l .Oml/min and a sample injection volume of 20,ul (running time of 46 min). Routine detection of colored carotenoids is at 450 nm, phytoene at 280 nm, and phytofluene at 365 nm. Spectral scans for peak purity were made at 250 nm and 600 nm. Spectra of peaks at the upslope, apex, and downslope are normalized and overlaid. Superimposing spectra were taken as evidence of peak purity. The results are shown in Table 10 below, and an HPLC chromatogram is shown in Figure 17. Table 9 below describes the relevant peak retention times shown in Figure 17. Carotenoid levels are presented as ,ug/gFW.

Table 9.

Ret Time Area Amt/Area Amount Compound [mini [mAU*s] [ug/gFW] Name 3.500 Astaxanthin 5.428 721.34 4.3x103 59.33 Lutein 5.831 169.38 4.26x10-3 13.81 Zeaxanthin 6.533 527.83 4.45x10-3 44.88 Canthaxanthin 7.651 553.82 3.59x10-3 38.02 Internal Std 14.403 Echinenone 18.453 68.21 7.02x10-3 9.16 Lycopene 22.278 Neurosporene 31.363 2966.38 3.52x103 199.36 oc-carotene 33.870 2854.27 3.86x10-3 210.64 -carotene 44.166 524.14 1.59x10-2 158.86 Phytoene Totals: 734.05

Table 10. Carotenoid concentrations of canola seeds from selected T2 6204-SP30021 lines.

Carotenoid Concentration (ug/ g FWt. ) Sample ID Segreg Lutein Canth Lycopene a-Carotene b-Carotene Phytoene Total ratio SP30021 homo 21 ND ND ND ND ND 21 3390-SP30021-12 homo 44 ND 9 416 578 279 1326 6204-SP30021-1 3:1 41 22 9 223 252 192 744 6204-SP30021-2 15:1 43 24 9 231 283 236 831 6204-SP30021-3 3:1 51 8 6 165 268 65 568 6204-SP30021-5 63:1 56 25 11 292 296 305 992 6204-SP30021-6 no fit 61 47 9 206 218 165 720 6204-SP30021-7 3:1 41 13 8 180 232 160 634 6204-SP30021-8 3:1 41 16 6 68 108 54 299 6204-SP30021-9 >63:1 57 39 10 233 245 245 837 6204-SP30021-10 no fit 33 9 7 165 24 103 343 6204-SP30021-11 3:1 39 7 9 198 266 145 662 6204-SP30021-12 15:1 40 15 10 212 281 172 734 6204-SP30021-13 15:1 52 44 9 207 223 247 788 6204-SP30021-15 no fit 54 20 8 ' 205 291 160 738 6204-SP30021-21 3:1 44 11 8 142 216 126 551 6204-SP30021-24 3:1 47 9 9 149 202 89 509 6204-SP30021-25 15:1 37 33 8 235 257 243 819 6204-SP30021-28 15:1 46 11 9 225 288 123 707 6204-SP30021-29 null 18 ND ND ND ND ND 18 6204-SP30021-30 3:1 33 11 8 203 246 154 659 6204-SP30021-36 15:1 31 17 7 197 275 95 628 6204-SP30021-37 3:1 38 10 7 137 181 117 490 6204-SP30021-41 3:1 42 9 8 250 339 170 821 6204-SP30021-42 3:1 32 4 6 178 216 103 539 6204-SP30021-43 15:1 54 25 10 242 304 151 792 6204-SP30021-44 no fit 48 27 7 226 249 129 692 The initial results demonstrate that as with plants transformed to express crtB alone, plants expressing crtB and crtW contain significant increases in total carotenoid levels. Furthermore, the results show an increase in the levels of canthaxanthin, when compared to the levels obtained from seeds of plants transformed with crtB alone, as well as nontransformed control plants. In addition, other products were also produced in plants expressing crtB and crtW. Increased levels of

echineone, a reaction intermediate, as well as a putative 4-keto-oc-carotene (Figure 17).

M. Carotenoid Analysis of Mature Seeds from crtB Transgenic Arabidopsis Plants Mature 3390 T2 seeds from Arabidopsis were collected and carotenoid extracts were prepared and analyzed according to the method described in 21 above.

These results are shown in Table 11 below. Carotenoid levels are presented as I.Lg/gFW.

Table 11. Carotenoids of T2 Arabidopsis seeds transformed with crtB.

Carotenoid concentration (llg/g FWt.) Date of Sample ID Harvest Lutein Lycopene a-Carotene -Carotene Phytoene Total AT001-50 VAR 6/4/98 18 ND ND 2 ND 20 3390-AT001-1 6/4/98 24 ND 7 20 7 58 3390-AT001-2 6/17/98 57 5 68 139 98 368 Initial results indicate that seeds from one line of Arabidopsis transformed with napin-crtB had an 18-fold increase in total carotenoid concentration. This line also demonstrate an approximately 70 fold increase in -carotene levels (Table 11).

Example 3 Crosses of crtB Plants A. Transgenic Oil Traits To evaluate the high oleic trait of the napin-cflB transgenic plants in conjunction with expression of other oils traits, crosses of fizz 3390-1-6-8 with a mangosteen thioesterase (5266) and a nutmeg thioesterase (3854; see WO 96/23892) were made. Crosses were also made with two low linoleic (LPO04 and LP30108) varieties. Half-seed analyses of carotenoids and fatty acid composition were conducted on the segregating seeds, and the average of the half seed values are shown below in Tables 12 and 13.

TABLE 12 Carotenoid Levels in Half Seeds Resulting from 3390 Crosses Cross Lutein Lvcopene a-Carotene -Carotene Total F13390-5P001-1-6-8xSP30021 21.6 26.2 271.5 413.1 732.4 F1 3390-SP001-1-6-8x5266-SP30021-5-26 18.0 21.7 187.9 284.1 511.7 F1 3390-SP001-1-6-8 x 5266-SP30021-35-2 16.2 22.1 223.0 318.4 579.7 F1 3390-SP001-1-6-8 x 5266-SP30021-35-12 19.5 22.9 196.8 312.8 552.0 F1 3390-SP001-1-6-8 x LP30108-19 23.7 22.7 213.4 355.0 614.8 F1 LP30108-19 xF1 3390-SP001-1-6-8 16.4 19.6 156.7 224.5 417.2 TABLE 13 Fattv Acid Composition in Half Seeds Resulting from 3390 Crosses STRAIN~ID %14:0 %16:0 %18:0 %18: 1 %18:2 %18:3 %20:0 (3390-SP001-1-6-8 X 0.05 3.55 1.70 74.78 11.29 5.71 0.73 SP30021) (3390-SP001-1-6-8 X 0.06 3.84 11.37 62.86 11.06 5.08 3.38 5266-SP30021-35-12) (3390-SP001-1-6-8 X 0.06 3.68 11.27 64.80 9.81 5.16 3.04 5266-SP30021-35-2) 3390-SPO01-1-6-8 X 0.06 3.66 15.36 60.78 9.30 4.77 3.87 5266-SP30021-5-26 (3390-SP001-1-6-1 X 2.69 9.80 3.65 64.62 9.72 4.57 1.51 3854-SP30021-20-3) (3390-SP001-1-6-1 X 6.14 16.35 5.12 54.91 8.23 4.23 2.03 3854-SP30021-20- 1) (3390-SP001-1-6-l X 0.07 3.82 11.67 64.52 11.46 3.14 3.08 5266-LP004-2-31) (3390-SP001-1-6-8 X 0.05 3.80 1.44 73.66 14.02 3.93 0.67 LP30108-19) (LP30108-19X 0.04 3.31 1.79 79.69 9.26 2.97 0.75 3390-SP001-1-6-8) SPOO1-4-10 0.07 4.44 0.99 56.06 21.79 14.31 0.44 3390-SPO01-1-6-8 0.04 3.46 1.44 77.26 9.30 5.71 0.63

As the above results demonstrate, a dramatic increase (100 to 200 fold) in ot- and p-carotene as well as a 60 fold increase in total carotenoids may be obtained by transformation of plants for expression of an early carotenoid biosynthesis gene under the regulatory control of promoter preferentially expressed in plant seed tissue. This increase in flux primes the pathway for the production of speciality products as described above, and also results in increased production of cc-tocopherol (Vitamin E).

Furthermore, it is evident that the fatty acid composition can also be altered in the transgenic plant seeds. In this manner, seeds can be used to produce novel products, to provide for production of particular carotenoids, to provide high oleic oils, and the like.

All publications and patent applications mentioned in the specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.